Bioventus/$BVS
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Bioventus
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Ticker
$BVS
Sector
Primary listing
Employees
940
Headquarters
Website
Bioventus Metrics
BasicAdvanced
$583m
21.33
$0.40
0.67
-
Price and volume
Market cap
$583m
Beta
0.67
52-week high
$11.25
52-week low
$5.81
Average daily volume
670k
Financial strength
Current ratio
1.687
Quick ratio
1.056
Long term debt to equity
113.337
Total debt to equity
123.117
Interest coverage (TTM)
2.58%
Profitability
EBITDA (TTM)
80.851
Gross margin (TTM)
68.69%
Net profit margin (TTM)
4.94%
Operating margin (TTM)
10.45%
Effective tax rate (TTM)
-2.67%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
5.61%
Return on equity (TTM)
16.46%
Valuation
Price to earnings (TTM)
21.335
Price to revenue (TTM)
0.999
Price to book
3.08
Price to tangible book (TTM)
-3.26
Price to free cash flow (TTM)
5.721
Free cash flow yield (TTM)
17.48%
Free cash flow per share (TTM)
1.503
Growth
Revenue change (TTM)
1.51%
Earnings per share change (TTM)
-177.54%
3-year revenue growth (CAGR)
3.89%
10-year revenue growth (CAGR)
8.05%
3-year earnings per share growth (CAGR)
-55.70%
10-year earnings per share growth (CAGR)
-21.84%
What the Analysts think about Bioventus
Analyst ratings (Buy, Hold, Sell) for Bioventus stock.
Bioventus Financial Performance
Revenues and expenses
Bioventus Earnings Performance
Company profitability
Bioventus News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs